The relationship between Na+/H+ exchanger expression and tyrosinase activity in human melanocytes

被引:85
作者
Smith, DR [1 ]
Spaulding, DT [1 ]
Glenn, HM [1 ]
Fuller, BB [1 ]
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA
关键词
amiloride; NHE; melanosome; V-ATPase; TRP-1; tyrosinase;
D O I
10.1016/j.yexcr.2004.04.033
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The activity of melanosome-associated tyrosinase in human melanocytes differs based on racial skin type. In melanocytes from Black skin, tyrosinase activity is high while in White melanocytes the activity of the enzyme is low. Recent studies suggest that low tyrosinase activity in White melanocytes may be due to an acidic pH environment within the melanosome. Because sodiurn/hydrogen (Na+/H+) exchangers (NHEs) are known to regulate intracellular pH, melanocytes were treated with NHE inhibitors to determine what effect this inhibition might have on tyrosinase activity. Treatment of Black melanocytes with ethyl-isopropyl amiloride (EIPA) caused a rapid dose-dependent inhibition of tyrosinase activity. This inhibition was not due to either direct enzyme inhibition or to a decrease in tyrosinase abundance. In contrast, treatment of White melanocytes with EIPA, cimetidine, or clonidine resulted in little inhibition of tyrosinase activity. Reverse transcriptase-polymerase chain reaction (RT-PCR) and Western blot analysis showed that both Black and White melanocytes expressed mRNA and protein for NHE-1, NHE-3, NHE-5, NHE-6, and NHE-7. Immunohistochemical analysis showed that NHE-7 and NHE-3 co-localized with the melanosomal protein, Tyrosinase Related Protein-1 (TRP-1). In addition, the vesicular proton pump, vesicular ATPase (V-ATPase), was found to be present in both White and Black melanosomes, indicating that organelles from both racial skin types are capable of being acidified. The results suggest that one or more NHEs may help regulate melanosoine pH and tyrosinase activity in human melanocytes. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:521 / 534
页数:14
相关论文
共 27 条
[1]   Melanosomal pH controls rate of melanogenesis, eumelanin/phaeomelanin ratio and melanosome maturation in melanocytes and melanoma cells [J].
Ancans, J ;
Tobin, DJ ;
Hoogduijn, MJ ;
Smit, NP ;
Wakamatsu, K ;
Thody, AJ .
EXPERIMENTAL CELL RESEARCH, 2001, 268 (01) :26-35
[2]   Proteomic analysis of early melanosomes: Identification of novel melanosomal proteins [J].
Basrur, V ;
Yang, F ;
Kushimoto, T ;
Higashimoto, Y ;
Yasumoto, K ;
Valencia, J ;
Muller, J ;
Vieira, WD ;
Watabe, H ;
Shabanowitz, J ;
Hearing, VJ ;
Hunt, DF ;
Appella, E .
JOURNAL OF PROTEOME RESEARCH, 2003, 2 (01) :69-79
[3]   Human Na+/H+ exchanger isoform 6 is found in recycling endosomes of cells, not in mitochondria [J].
Brett, CL ;
Wei, Y ;
Donowitz, M ;
Rao, R .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2002, 282 (05) :C1031-C1041
[4]   Correction of defective early tyrosinase processing by bafilomycin A1 and monensin in pink-eyed dilution melanocytes [J].
Chen, K ;
Minwalla, L ;
Ni, L ;
Orlow, SJ .
PIGMENT CELL RESEARCH, 2004, 17 (01) :36-42
[5]  
Chiu HM, 1998, CHINESE J PHYSIOL, V41, P195
[6]   The expanding family of eucaryotic Na+/H+ exchangers [J].
Counillon, L ;
Pouysségur, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (01) :1-4
[7]   The epithelial sodium-hydrogen antiporter Na+/H+ exchanger 3 accumulates and is functional in recycling endosomes [J].
D'Souza, S ;
Garcia-Cabado, A ;
Yu, F ;
Teter, K ;
Lukacs, G ;
Skorecki, K ;
Moore, HP ;
Orlowski, J ;
Grinstein, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (04) :2035-2043
[8]   HORMONAL-REGULATION OF MELANOGENESIS IN MOUSE MELANOMA AND IN HUMAN MELANOCYTES [J].
FULLER, BB ;
RUNGTA, D ;
IOZUMI, K ;
HOGANSON, GE ;
CORN, TD ;
CAO, VA ;
RAMADAN, ST ;
OWENS, KC .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1993, 680 :302-319
[9]  
FULLER BB, 1987, J BIOL CHEM, V262, P4024
[10]   Downregulation of tyrosinase activity in human melanocyte cell cultures by yohimbine [J].
Fuller, BB ;
Drake, MA ;
Spaulding, DT ;
Chaudhry, F .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 114 (02) :268-276